News & Events
-
April 17, 2019 - April 18, 2019
2019 PSTC Japan Safety Biomarker Conference
Summary With the cooperation and support of RIKEN, NIHS, JSOT and JPMA, the Predictive Safety Testing Consortium (PSTC) of the Critical Path Institute hosted the 2nd PSTC Japan Safety Biomarker Conference from April 17-18, 2019 in Yokohama, Japan. The utilization of biomarkers in guiding drug development decisions through clinical trials and post marketing studies is...... - March 13, 2019 - March 16, 2019
-
November 13, 2018
Critical Path for Alzheimer’s Disease 2018 Annual Meeting and Regulatory Science Workshop
November 13, 2018 Overview and Objectives: The Critical Path for Alzheimer’s Disease (CPAD) is a public-private partnership aimed at creating new tools and methods that can be applied to increase the efficiency of the development process leading to treatments for neurodegenerative diseases that progress to dementia with the shared characteristics of Alzheimer disease (AD), the...... -
October 30, 2018
Webinar Recording Available: Acetaminophen-Induced Liver Toxicity Mechanisms, Diagnosis and Treatment
Members of C-Path’s Predictive Safety Testing Consortium (PSTC) were among the featured facilitators and speakers of an educational webinar, sponsored and hosted by the Clinical and Translational Toxicology Specialty Section of the Society of Toxicology, on acetaminophen (APAP) induced liver toxicity. With a duration of 1 hour and 12 minutes, this Oct. 30, 2018 event...... -
October 24, 2018 - October 27, 2018
11th Clinical Trials on Alzheimer’s Disease (CTAD)
The Clinical Trials on Alzheimer’s Disease (CTAD) conference is an important annual scientific meeting where latest developments and research results from clinical Alzheimer disease trials are shared and discussed. Researchers and participants from pharma, academia, patent-advocacy organizations and other groups are coming together in Barcelona, Spain, between October 24th and 27th. Each year, on behalf......